TATVA CHINTAN PHARMA CHEM Q4 RESULTS LIVE : PROFIT FALLS BY 43.31% YOY

Tatva Chintan Pharma Chem Q4 Results Live : Tatva Chintan Pharma Chem declared their Q4 results on 03 May, 2024. The topline decreased by 21.08% & the profit decreased by 43.31% YoY. As compared to the previous quarter the revenue grew by 16.7% and the profit increased by 178.26%.

The Selling, general & administrative expenses declined by 2.71% q-o-q & increased by 39.14% Y-o-Y.

The operating income was up by 112.56% q-o-q & decreased by 31.8% Y-o-Y.

The EPS is ₹4.11 for Q4 which decreased by 52.78% Y-o-Y.

Tatva Chintan Pharma Chem has delivered -1.97% return in the last 1 week, -14.66% return in last 6 months and -23.33% YTD return.

Currently the Tatva Chintan Pharma Chem has a market cap of ₹2872.89 Cr and 52wk high/low of ₹1887.95 & ₹1061.35 respectively.

As of 05 May, 2024 out of 5 analysts covering the company, 1 analyst has given Sell rating, 1 analyst has given Hold rating, 1 analyst has given Buy rating &2 analysts have given Strong Buy rating.

The consensus recommendation as on 05 May, 2024 was to Buy.

Stay updated on quarterly results with our results calendar

2024-05-04T21:17:50Z dg43tfdfdgfd